Antibody Pair for Apolipoprotein B (APOB) 
Apo-B; FLDB; Apo B-100
- UOM
- FOB US$ 1,231.00 US$ 2,052.00 US$ 3,694.00 US$ 7,182.00 US$ 12,312.00
- Quantity
Overview
Properties
- Product No.PSC003Ra01
- Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
- ApplicationsELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
Research use only - Downloadn/a
- CategoryMetabolic pathwayEndocrinologyCardiovascular biologyHepatologyNutrition metabolism
-
Reagent Contents
Recombinant Apolipoprotein B (APOB) 50ug Standard Monoclonal Antibody to Apolipoprotein B (APOB) 500ug Capture Ab Biotin-Linked Monoclonal Antibody to Apolipoprotein B (APOB) 200ug Detection Ab
Sign into your account
Share a new citation as an author
Upload your experimental result
Review
Contact us
Please fill in the blank.
-
Packages (Simulation)
-
Packages (Simulation)
-
ISO9001: 2008, ISO13485: 2003 Registered
Matching tests
Usage
The concentration of protein/peptide and antibodies used in different immunoassays need to be determined by users according to their experiments.
Storage
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Giveaways
Increment services
Citations
- Group 1B phospholipase A2 deficiency protects against diet-induced hyperlipidemia in miceJlr: M019463
- Elevated retinol binding protein 4 induces apolipoprotein B production and associates with hypertriglyceridemiaPubmed:25781360
- Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolismPubMed: 26515253
- Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein (a) in transgenic micePubMed: 26064792
- Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of LDL receptor degradationPubmed:27284008
- COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXESy2016:0152988.html
- Hops (Humulus lupulus) Content in Beer Modulates Effects of Beer on the Liver After Acute Ingestion in Female Mice.pubmed:27659607
- Change in the Lipid Transport Capacity of the Liver and Blood during Reproduction in Ratspubmed:28798692
- Wild Lonicera caerulea berry polyphenol extract reduces cholesterol accumulation and enhances antioxidant capacity in vitro and in vivoPubmed:29580541
- Consumption of orange fermented beverage improves antioxidant status and reduces peroxidation lipid and inflammatory markers in healthy humansPubmed:29124773
- The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in?…Pubmed: 30768981
- Hepatic HuR modulates lipid homeostasis in response to high-fat dietPubmed: 32546794
- Study of in Vivo Serum Lipid Regulation with Ulmus macrocarpa Hance Extract in Rats
- GP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity34853313